The cancer imaging archive (tcia) clinical trial data expansion
Ended Awarded Last action
- Contract number
- 75N91018F00074
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $5,261,900
Award facts
- Opportunity
-
- N01CO5240180 Solicitation number
- Operations and Technical Support for the Frederick National Laboratory for Cancer Research (FLNCR), a Federally Funded Research and Development Center (FFRDC) Award Notice · Posted Apr 27, 2015
- Contract value 100% obligated
- $5,261,900.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 561210 Facilities Support Services
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
This is a federal contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Cancer Institute to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The $5,261,900.00 contract is for the expansion of clinical trial data for The Cancer Imaging Archive (TCIA). The contract is a delivery order with a cost-plus-fixed-fee pricing type and a completion date of September 23, 2023. Leidos Biomedical Research has a broad Federally Funded Research and Development Center (FFRDC) contract with the National Cancer Institute valued at up to $6.6 billion. Through this FFRDC and other past awards, Leidos Biomedical Research has provided a range of biomedical research support services to NIH institutes, including facilities operations, research and development, manufacturing, and clinical trials management. The contract does not have a set-aside designation.
Quick answers
Who was awarded contract 75N91018F00074?
75N91018F00074 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on September 24, 2018.
How much is contract 75N91018F00074 worth?
The government has obligated $5,261,900 on 75N91018F00074.
Is contract 75N91018F00074 an order under another contract?
Yes. 75N91018F00074 is a delivery order under HHSN261201500003I, an indefinite delivery contract.
Was contract 75N91018F00074 competed?
The extent of competition for 75N91018F00074 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award